Fund Holdings — VR Adviser, LLC

Total Portfolio Value:
$1.46B
Total Bought:
$598.68M
Total Sold:
$157.76M
Net Transaction:
+$440.91M
Notable People:
Evan Wolfe Neu, Jessica Tong Baron
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Rayzebio Inc4,016,8474,030,471+13,624$89.17M$250.57M17.19%+$161.40M
Apogee Therapeutics Inc8,493,3218,493,3210$180.91M$237.30M16.28%+$56.40M
Pharvaris N V
COM
1,563,5133,395,606+1,832,093$32.63M$95.25M6.53%+$62.62M
Viridian Therapeutics, Inc.(VRDN)3,082,6223,882,623+800,001$47.29M$84.56M5.80%+$37.28M
4d Molecular Therapeutics In3,000,0003,424,031+424,031$38.19M$69.37M4.76%+$31.18M
Merus N V1,726,2142,148,214+422,000$40.70M$59.08M4.05%+$18.37M
Cabaletta Bio, Inc.(CABA)1,973,2532,563,952+590,699$30.03M$58.20M3.99%+$28.17M
Spyre Therapeutics, Inc.(SYRE)02,372,714+2,372,714$0$51.06M3.50%+$51.06M
Kalvista Pharmaceuticals Inc2,916,6674,092,731+1,176,064$28.09M$50.14M3.44%+$22.05M
Enliven Therapeutics Inc2,954,9022,954,9020$40.36M$40.90M2.80%+$531.9K
Ocular Therapeutix, Inc.(OCUL)07,775,760+7,775,760$0$34.68M2.38%+$34.68M
Hillevax Inc2,037,3132,075,000+37,687$27.40M$33.30M2.28%+$5.90M
Ambrx Biopharma Inc02,070,000+2,070,000$0$29.48M2.02%+$29.48M
Terns Pharmaceuticals Inc3,092,2734,497,117+1,404,844$15.55M$29.19M2.00%+$13.63M
Dyne Therapeutics, Inc.(DYN)2,173,9132,173,9130$19.48M$28.91M1.98%+$9.43M
Cogent Biosciences, Inc.(COGT)4,684,1674,684,1670$45.67M$27.54M1.89%-$18.13M
Celcuity Inc.(CELC)2,105,3861,885,538-219,848$19.24M$27.47M1.88%+$8.23M
Mersana Therapeutics Inc11,328,00011,328,0000$14.39M$26.28M1.80%+$11.89M
Arvinas, Inc.(ARVN)0627,788+627,788$0$25.84M1.77%+$25.84M
Astria Therapeutics Inc03,225,806+3,225,806$0$24.77M1.70%+$24.77M
Rhythm Pharmaceuticals, Inc.(RYTM)1,090,000495,983-594,017$24.99M$22.80M1.56%-$2.19M
ORIC Pharmaceuticals, Inc.(ORIC)2,142,8562,428,385+285,529$12.96M$22.34M1.53%+$9.38M
Applied Therapeutics Inc5,658,0346,250,000+591,966$14.09M$20.94M1.44%+$6.85M
Taysha Gene Therapies, Inc.(TSHA)14,444,44410,412,872-4,031,572$45.64M$18.43M1.26%-$27.21M
Savara Inc.(SVRA)7,184,8653,500,000-3,684,865$27.16M$16.45M1.13%-$10.71M
Lyra Therapeutics Inc924,1702,575,593+1,651,423$3.61M$13.50M0.93%+$9.88M
ABIVAX Société AnonymeADS(ABVX)0998,570+998,570$0$10.68M0.73%+$10.68M
Dianthus Therapeutics, Inc.(DNTH)927,706927,7060$12.68M$9.65M0.66%-$3.03M
Praxis Precision Medicines, Inc.(PRAX)0353,626+353,626$0$7.88M0.54%+$7.88M
GH Research PLC(GHRS)2,744,1251,318,327-1,425,798$27.58M$7.65M0.52%-$19.93M
Acelyrin Inc864,332937,113+72,781$8.79M$6.99M0.48%-$1.80M
EyePoint, Inc.(EYPT)0250,000+250,000$0$5.78M0.40%+$5.78M
Trevi Therapeutics, Inc.(TRVI)3,422,3973,422,3970$7.46M$4.59M0.31%-$2.87M
Adverum Biotechnologies Inc6,573,3005,147,547-1,425,753$9.86M$3.88M0.27%-$5.98M
Milestone Pharmaceuticals Inc.(MIST)2,208,812925,048-1,283,764$6.85M$1.54M0.11%-$5.30M
Olema Pharmaceuticals, Inc.(OLMA)77,04277,0420$951.5K$1.08M0.07%+$129.4K
ACLARIS THERAPEUTICS INCCOM(ACRS)1,040,7540-1,040,754$7.13M$0—-$7.13M
AEGLEA BIOTHERAPEUTICS INCCOM295,0340-295,034$3.61M$0—-$3.61M
AFFIMED N VCOM1,428,5710-1,428,571$682.7K$0—-$682.7K
AMBRX BIOPHARMA INCSPONSORED ADS2,070,0000-2,070,000$23.80M$0—-$23.80M
PLIANT THERAPEUTICS INCCOM(PLRX)288,9490-288,949$5.01M$0—-$5.01M
PRAXIS PRECISION MEDICINES ICOM5,304,4100-5,304,410$9.07M$0—-$9.07M
RALLYBIO CORPCOM(RLYB)268,5320-268,532$905.0K$0—-$905.0K
SAGIMET BIOSCIENCES INCCOM SER A(SGMT)515,0000-515,000$4.53M$0—-$4.53M
TRAVERE THERAPEUTICS INCCOM(TVTX)2,623,6770-2,623,677$23.46M$0—-$23.46M
Page 1 of 1
VR Adviser, LLC — 13F Holdings — Q4 2023 | TickerTrail